DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations
Francesco Giganti(University College Hospital), Valeria Panebianco(Sapienza University of Rome), Shonit Punwani(Royal Free London NHS Foundation Trust), Alex Kirkham, Carlo Catalano(Unknown), Riccardo Campa(Sapienza University of Rome), Mark Emberton(University College London), Francesco Del Giudice(Sapienza University of Rome), Clare Allen(St Peter's Hospital), Caroline M. Moore(University College London Hospitals NHS Foundation Trust), Davide Fierro(Sapienza University of Rome), Martina Pecoraro(Sapienza University of Rome)
Cited by 22
Related Papers
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
|The Lancet|2017|3.2k
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|618
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212